Poor sleep raises cortisol, lowers leptin sensitivity, and increases ghrelin, the hunger hormone
Oral administration of PF-06882961 shows evidence of glucose-lowering in healthy human study participants PF-06882961 was selected as a candidate for clinical studies based on its in vitro and in vivo pharmacologic and disposition profile, including potent agonism of the GLP-1R, preclinical disposition attributes (e.g., low metabolic CL int in human hepatocytes), good safety margins versus the hERG channel (IC 50 = 4.3 M, Table S4) and broad panel screening (Table S8), and selectivity versus related class B GPCRs (Table S9)
Always consult your physician before starting, stopping, or changing any medication.
While you can't get a Retatrutide prescription today, knowing its potential impact is important as you explore options in medical weight loss in Wausau